About NAPIGEN
NAPIGEN is a company based in Wilmington (United States) founded in 2016 by Roger Wyse. NAPIGEN has raised $8 million across 5 funding rounds from investors including HHS, RA Capital and Grantham Foundation. The company has 13 employees as of December 31, 2024. NAPIGEN offers products and services including Genome Editing Services. NAPIGEN operates in a competitive market with competitors including Corteva Agriscience, Syngenta, Mahyco, Nuziveedu Seeds and Protealis, among others.
- Headquarter Wilmington, United States
- Employees 13 as on 31 Dec, 2024
- Founders Roger Wyse
-
Sectors
Agriculture
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Napigen, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$8 M (USD)
in 5 rounds
-
Latest Funding Round
$175 K (USD), Grant
Jul 01, 2024
-
Investors
HHS
& 6 more
-
Employee Count
13
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of NAPIGEN
NAPIGEN offers a comprehensive portfolio of products and services, including Genome Editing Services.
Offers tools for editing mitochondrial and chloroplast genomes in research.
People of NAPIGEN
Unlock access to complete
Unlock access to complete
Funding Insights of NAPIGEN
NAPIGEN has successfully raised a total of $8M across 5 strategic funding rounds. The most recent funding activity was a Grant round of $175 thousand completed in July 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in NAPIGEN
NAPIGEN has secured backing from 7 investors, including institutional and venture fund investors. Prominent investors backing the company include HHS, RA Capital and Grantham Foundation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage bioscience entrepreneurs are supported through venture capital.
|
Locked | Locked | Locked | |
|
Food and agtech startups are accelerated by THRIVE programs.
|
Locked | Locked | Locked | |
|
Early-stage science-driven companies are supported through venture capital investments.
|
Locked | Locked | Locked |
Investor details for NAPIGEN
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by NAPIGEN
Investment portfolio details for NAPIGEN
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - NAPIGEN
Detailed financials for NAPIGEN
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Napigen Comparisons
Peer comparison for NAPIGEN
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of NAPIGEN
NAPIGEN operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Corteva Agriscience, Syngenta, Mahyco, Nuziveedu Seeds and Protealis, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Manufacturer and supplier of agricultural farm inputs
|
|
| Locked | Locked | Locked |
Crop protection solutions and hybrid seeds are provided for farming.
|
|
| Locked | Locked | Locked |
Agriculture company offering hybrid and open pollinated seeds
|
|
| Locked | Locked | Locked |
Improved crop varieties and hybrids are developed and marketed.
|
|
| Locked | Locked | Locked |
Hybrid field crop seeds are supplied to farmers.
|
Detailed competitors of NAPIGEN
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Napigen
Complete news archive for NAPIGEN
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about NAPIGEN
NAPIGEN was founded in 2016 and raised its 1st funding round 2 years after it was founded.
NAPIGEN is headquartered in Wilmington, United States. It is registered at Wilmington, Delaware, United States.
NAPIGEN is a funded company, having raised a total of $8M across 5 funding rounds to date.
As of Dec 31, 2024, the latest employee count at NAPIGEN is 13.
NAPIGEN was founded in 2016 and is based in Wilmington, United States. Non-GMO hybrid seeds for autogamous cereals are developed by the company to improve crop yields through hybrid vigor. Proprietary hybridization and genome engineering methods are utilized in operations within the agritech sector. Focus is placed on enhancing agricultural productivity without genetic modification.
NAPIGEN's top competitors include Syngenta, Mahyco and Corteva Agriscience.
NAPIGEN offers Genome Editing Services.
NAPIGEN has 7 investors. Key investors include HHS, RA Capital, Grantham Foundation, Umdf, and MarsBio.